231 related articles for article (PubMed ID: 24388569)
41. Development of platelet contractile force as a research and clinical measure of platelet function.
Carr ME
Cell Biochem Biophys; 2003; 38(1):55-78. PubMed ID: 12663942
[TBL] [Abstract][Full Text] [Related]
42. [Platelets: biochemistry and physiology].
Kehrel BE
Hamostaseologie; 2008 Dec; 28(5):289-98. PubMed ID: 19132160
[TBL] [Abstract][Full Text] [Related]
43. Modelling of platelet-fibrin clot formation in flow with a DPD-PDE method.
Tosenberger A; Ataullakhanov F; Bessonov N; Panteleev M; Tokarev A; Volpert V
J Math Biol; 2016 Feb; 72(3):649-81. PubMed ID: 26001742
[TBL] [Abstract][Full Text] [Related]
44. Effect of non-heparin thrombin antagonists on thrombin generation, platelet function, and clot structure in whole blood.
Carr ME; Angchaisuksiri P; Carr SL; Martin EJ
Cell Biochem Biophys; 2003; 39(2):89-99. PubMed ID: 14515016
[TBL] [Abstract][Full Text] [Related]
45. [Blood platelets: biochemistry and physiology].
Kehrel BE
Hamostaseologie; 2003 Nov; 23(4):149-58. PubMed ID: 14603379
[TBL] [Abstract][Full Text] [Related]
46. Interplay of Platelet Contractility and Elasticity of Fibrin/Erythrocytes in Blood Clot Retraction.
Tutwiler V; Wang H; Litvinov RI; Weisel JW; Shenoy VB
Biophys J; 2017 Feb; 112(4):714-723. PubMed ID: 28256231
[TBL] [Abstract][Full Text] [Related]
47. Glycyrrhizae Radix attenuates peroxynitrite-induced renal oxidative damage through inhibition of protein nitration.
Yokozawa T; Cho EJ; Rhyu DY; Shibahara N; Aoyagi K
Free Radic Res; 2005 Feb; 39(2):203-11. PubMed ID: 15763968
[TBL] [Abstract][Full Text] [Related]
48. A new plasma-adapted hydroxyethyl starch preparation: in vitro coagulation studies.
Boldt J; Mengistu A
J Cardiothorac Vasc Anesth; 2010 Jun; 24(3):394-8. PubMed ID: 20005132
[TBL] [Abstract][Full Text] [Related]
49. Resveratrol protects against peroxynitrite-induced thiol oxidation in blood platelets.
Olas B; Nowak P; Wachowicz B
Cell Mol Biol Lett; 2004; 9(4A):577-87. PubMed ID: 15647782
[TBL] [Abstract][Full Text] [Related]
50. The effects of fibrinogen levels on thromboelastometric variables in the presence of thrombocytopenia.
Lang T; Johanning K; Metzler H; Piepenbrock S; Solomon C; Rahe-Meyer N; Tanaka KA
Anesth Analg; 2009 Mar; 108(3):751-8. PubMed ID: 19224779
[TBL] [Abstract][Full Text] [Related]
51. Platelet microtubules in clot structure formation and contractile force generation: investigation of a controversy.
Jen CJ; McIntire LV
Thromb Haemost; 1986 Aug; 56(1):23-7. PubMed ID: 2877507
[TBL] [Abstract][Full Text] [Related]
52. [Variant of Paris-I Lariboisière thrombasthenia, a molecular anomaly of the IIb-IIIa platelet glycoprotein complex].
Caen JP; Rosa JP; Soria C; Boizard B
C R Seances Acad Sci III; 1983; 296(10):479-81. PubMed ID: 6223690
[TBL] [Abstract][Full Text] [Related]
53. Asymmetrical Forces Dictate the Distribution and Morphology of Platelets in Blood Clots.
Kovalenko TA; Giraud MN; Eckly A; Ribba AS; Proamer F; Fraboulet S; Podoplelova NA; Valentin J; Panteleev MA; Gonelle-Gispert C; Cook S; Lafanechère L; Sveshnikova AN; Sadoul K
Cells; 2021 Mar; 10(3):. PubMed ID: 33800866
[TBL] [Abstract][Full Text] [Related]
54. Dynamic coagulation studies: influence of normal and abnormal platelets on clot structure formation.
Glover CJ; McIntire LV; Brown CH; Natelson EA
Thromb Res; 1975 Jul; 7(1):185-98. PubMed ID: 1154337
[No Abstract] [Full Text] [Related]
55. Biphasic myosin II light chain activation during clot retraction.
Egot M; Kauskot A; Lasne D; Gaussem P; Bachelot-Loza C
Thromb Haemost; 2013 Dec; 110(6):1215-22. PubMed ID: 23965920
[TBL] [Abstract][Full Text] [Related]
56. [Effect of ischemic heart disease risk factors on plasma and vascular-thrombocyte hemostasis].
Gribauskas PS; Rudzhionene IaI
Kardiologiia; 1981 Aug; 21(8):57-63. PubMed ID: 7289385
[TBL] [Abstract][Full Text] [Related]
57. A Miniaturized Hemoretractometer for Blood Clot Retraction Testing.
Li Z; Li X; McCracken B; Shao Y; Ward K; Fu J
Small; 2016 Aug; 12(29):3926-34. PubMed ID: 27248117
[TBL] [Abstract][Full Text] [Related]
58. Activated Monocytes Enhance Platelet-Driven Contraction of Blood Clots via Tissue Factor Expression.
Peshkova AD; Le Minh G; Tutwiler V; Andrianova IA; Weisel JW; Litvinov RI
Sci Rep; 2017 Jul; 7(1):5149. PubMed ID: 28698680
[TBL] [Abstract][Full Text] [Related]
59. Ultrasound enhanced synthetic platelet therapy for augmented wound repair.
Nandi S; Mohanty K; Nellenbach K; Erb M; Muller M; Brown AC
ACS Biomater Sci Eng; 2020 May; 6(5):3026-3036. PubMed ID: 33313395
[TBL] [Abstract][Full Text] [Related]
60. Ionophore a 23187: some effects on platelet aggregation and clot retraction.
Bottecchia D; Fantin G; Gruppo F; Nassuato G
Haemostasis; 1976; 5(3):176-88. PubMed ID: 793958
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
